ArticleNucleic acids research2026
Engineering of tRNAPro1E2 anticodon stem enhances multiple/consecutive ribosomal incorporation of N-methyl-l-α-amino acids and d-α-amino acids.
Article in Nucleic acids research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Transfer RNA (tRNA) structures influence the incorporation efficiency of amino acids, particularly when nonproteinogenic amino acids (npAAs), such as N-methyl-l-α-amino acids (MeAAs) and d-α-amino acids (d-AAs), are charged. Such npAAs are generally far poorer substrates than the 20 canonical α-amino acids for translation. However, we have shown that their incorporation efficiencies could be improved by using a chimeric tRNA, termed tRNAPro1E2, bearing optimal T-stem and D-arm. Here we report that the engineering anticodon stem of tRNAPro1E2 further enhances multiple/consecutive elongation of MeAAs and d-AAs. By screening 149 types of anticodon stem mutants, we found eleven tRNAPro1E2 variants capable of enhancing the incorporation of N-methyl-l-leucine (MeLeu) or d-phenylalanine (d-Phe) at six codons by up to 4.5- and 4.4-fold, respectively. Interestingly, 7 out of the 11 variants showed different mobilities compared to the parental tRNAsPro1E2 in native polyacrylamide gel electrophoresis analysis, indicating that their unique conformations contributed to promoting peptidyl transfer reaction. These tRNAs exhibited increased incorporation efficiencies of not only MeLeu and d-Phe but also diverse MeAAs and d-AAs. Ribosomal synthesis of a model macrocyclic peptide containing three consecutive MeAAs and three d-AAs was also demonstrated with high quality, indicating their usefulness for the peptide library construction containing multiple exotic amino acids.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.